Sejong Medical Competitors and Similar CompaniesClear all

Sejong Medical's competitors and similar companies include Medtronic Minimally Invasive Therapies Group, Arthrex and Alcon.

	Sejong Medical Sejong Medical (세종메디칼) is a manufacturer of laparoscopic surgery systems and equipment.	Medtronic Minimally Invasive Therapies Group Medtronic Minimally Invasive Therapies Group (also known as Covidien) is a company providing medical devices and supplies.	Arthrex Arthrex is a company specializing in the development and manufacturing of medical devices for minimally invasive orthopedic surgery.	Alcon Alcon is a company that manufactures surgical and vision care products.
Founding Date	Founding Date 1996	Founding Date 2007	Founding Date 1981	Founding Date 1945
Type	Type Public	Type Subsidiary	Type Private	Type Public
Tags	Tags Healthcare medical devices surgical solutions	Tags Healthcare medical devices surgical solutions	Tags Healthcare medical devices surgical solutions	Tags Healthcare eyewear medical devices optics pharmacy
Locations	Locations Paju-si, KR HQ	Locations Dublin, IE HQ	Locations Naples, US HQ Frenchs Forest, AU Kontich, BE Zagreb, HR see more	Locations Geneva, CH HQ Macquarie Park, AU Wien, AT Mechelen, BE Mississauga, CA Beijing, CN Praha, CZ see more
Employees	Employees 135	Employees 7,784	Employees 8,4171% increase	Employees 25,000
Financial
Revenue (est.)	Revenue (est.) ₩19b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) $2b (FY, 2017)	Revenue (est.) $10.4b (FY, 2025)
Cost of goods	Cost of goods ₩9.7b (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods $3.4b (FY, 2025)
Gross profit	Gross profit ₩10.8b (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit $7.2b (FY, 2025)
Net income	Net income (₩72.1b) (FY, 2024)	Net income N/A	Net income N/A	Net income $980m (FY, 2025)
Operating ⚠
Product Categories	Product Categories N/A	Product Categories 39 (Oct, 2023)	Product Categories N/A	Product Categories 6 (Sep, 2022)
Solutions	Solutions N/A	Solutions 22 (Oct, 2023)	Solutions N/A	Solutions 4 (Sep, 2022)